Skip to content
MedsAcross

Medicine

Albuterol 4 mg tablet

Albuterol · Oral
Available on requestPrescription onlyUS FDAGeneric name

Albuterol 4 mg tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). Protect from light.

Key facts

Active ingredient (INN)
Albuterol
Brand
Sold under the generic name
Strength
4 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 50 tablets and 23 more
Manufacturers
Sun Pharmaceutical IndustriesIndiaZydus LifesciencesIndiaAurobindo PharmaIndiaProficient RxBryant Ranch PrepackAmneal Pharmaceuticals NYRising Pharma HoldingsChartwell RXGolden State Medical Supply
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
R03AC02 Albuterol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
5 December 1989
Identifiers
RxCUI 197316, 197318DailyMed set ID c3fa0068-fd12-45de-818e-e929fb45ba05, a22af54a-c010-ab8b-e053-2a95a90a8862, 601a18ed-d66e-498f-a804-f1a3330827d4 +7NDC 70710-1062, 51407-368, 63629-2611 +7Application ANDA208884, ANDA072637, ANDA207046 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle70710-1062-1Zydus LifesciencesIndia23 October 2020
500 tablet in 1 bottle70710-1062-5Zydus LifesciencesIndia23 October 2020
100 tablet in 1 bottle70771-1512-1Zydus LifesciencesIndia23 October 2020
500 tablet in 1 bottle70771-1512-5Zydus LifesciencesIndia23 October 2020
100 tablet in 1 bottle59651-334-01Aurobindo PharmaIndia14 May 2020
500 tablet in 1 bottle59651-334-05Aurobindo PharmaIndia14 May 2020
100 tablet in 1 bottle53489-177-01Sun Pharmaceutical IndustriesIndia5 December 1989
50 tablet in 1 bottle53489-177-02Sun Pharmaceutical IndustriesIndia5 December 1989
250 tablet in 1 bottle53489-177-03Sun Pharmaceutical IndustriesIndia5 December 1989
500 tablet in 1 bottle53489-177-05Sun Pharmaceutical IndustriesIndia5 December 1989
1000 tablet in 1 bottle53489-177-10Sun Pharmaceutical IndustriesIndia5 December 1989
100 tablet in 1 bottle69238-1345-1Amneal Pharmaceuticals NY24 May 2018
500 tablet in 1 bottle69238-1345-5Amneal Pharmaceuticals NY24 May 2018
90 tablet in 1 bottle62135-672-90Chartwell RX14 June 2023
100 tablet in 1 bottle64980-443-01Rising Pharma Holdings29 June 2018
500 tablet in 1 bottle64980-443-50Rising Pharma Holdings29 June 2018
20 tablet in 1 bottle63629-2611-1Bryant Ranch Prepack8 April 2025
30 tablet in 1 bottle63629-2611-2Bryant Ranch Prepack8 April 2025
60 tablet in 1 bottle63629-2611-3Bryant Ranch Prepack8 April 2025
100 tablet in 1 bottle51407-368-01Golden State Medical Supply26 March 2020
100 tablet in 1 bottle71205-899-00Proficient Rx30 July 2021
1000 tablet in 1 bottle71205-899-11Proficient Rx30 July 2021
30 tablet in 1 bottle71205-899-30Proficient Rx30 July 2021
500 tablet in 1 bottle71205-899-55Proficient Rx30 July 2021
60 tablet in 1 bottle71205-899-60Proficient Rx30 July 2021
90 tablet in 1 bottle71205-899-90Proficient Rx30 July 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 1 May 1981Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Albuterol

Clinical summary

Albuterol is a beta2-adrenergic agonist indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. MedsAcross supplies Albuterol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Albuterol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Albuterol 4 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.